Product Information
GNP ANTI-NAUSEA LIQUID is a generic product labeled by AmerisourceBergen, priced at $0.0235 per ML under NDC 46122072926. Its NADAC has been published 161 times since Sep 6, 2023.
Strength
1.87; 1.87; 21.5 g/5mL; g/5mL; mg/5mL
Manufacturer
AmerisourceBergenNDC
46122072926
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROSE, UNSPECIFIED FORM; FRUCTOSE; PHOSPHORIC ACIDApproval Type
Unapproved
On Market Since
5/1/2023
Price Statistics
The NADAC for GNP ANTI-NAUSEA LIQUID has been published 161 times since Sep 6, 2023, and over the history we have for it it has risen 5.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0235 per ML |
|---|---|
| All-time high | $0.0267 (Mar 13, 2024) |
| All-time low | $0.0198 (Nov 20, 2024) |
| 52-week high | $0.0239 |
| 52-week low | $0.0218 |
| Median price | $0.0223 |
| Average price | $0.0223 |
| Largest weekly change | +28.5% (Jan 17, 2024) |
| Weeks tracked | 161 |
| Tracking since | Sep 6, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dextrose(glucose),Levulose(fructose),Phosphoric acid market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP ANTI-NAUSEA LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for GNP ANTI-NAUSEA LIQUID, manufactured by AmerisourceBergen, is $0.0235 per ML (NDC 46122072926), effective Sep 30, 2026.
How has the price of GNP ANTI-NAUSEA LIQUID changed over time?
Over the history we have for it, the NADAC for GNP ANTI-NAUSEA LIQUID has risen 5.0%. It has been tracked across 161 weekly CMS publications since Sep 6, 2023.
What are the highest and lowest recorded NADAC prices for GNP ANTI-NAUSEA LIQUID?
Since Sep 6, 2023, the NADAC for GNP ANTI-NAUSEA LIQUID has ranged from a low of $0.0198 (Nov 20, 2024) to a high of $0.0267 (Mar 13, 2024), with a median of $0.0223 per ML.
Are there cheaper alternatives to GNP ANTI-NAUSEA LIQUID?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GNP ANTI-NAUSEA LIQUID in a comparable dosage form, but none are currently priced below it.
Who manufactures GNP ANTI-NAUSEA LIQUID?
GNP ANTI-NAUSEA LIQUID (NDC 46122072926) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.